NE has also been shown to accelerate pancreatic cancer PNI and progression through the β-AR/PKA/STAT3 signaling pathway in vivo, where the activation of STAT3 upregulates the downstream expression levels of NGF and MMPs (Guo et al., 2013). Here, STAT3 is linked to pancreatic neoplasm.